New US Patent for Solidia Technologies’ CO2-cured Concrete Advances Performance and Sustainability of Building Materials
The U.S. Patent and Trademark Office issued a patent for the structure of CO2 -cured Solidia Concrete™, advancing the performance and sustainability of materials available to the global construction and materials industries. Solidia Technologies® holds the exclusive licensing rights to the patent, which is held by Rutgers University , where the original generation of the material was invented.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180119005608/en/
U.S. Patent No. 9,868,667 , "Bonding Element, Bonding Matrix and Composite Material Having the Bonding Element and Method of Manufacturing Thereof," covers the composition of matter of the non-hydraulic concrete.
“The hydrate bonds in conventional concrete can compromise that material’s strength and durability,” explained Solidia Chief Technology Officer Nicholas DeCristofaro, Ph.D. “With CO2 -cured concrete, bonding elements based on silica and calcium carbonate create a wide range of attractive properties, including mechanical strength, resistance to freeze-thaw deterioration, and resistance to sulfate attack.”
Solidia addresses the cement industry’s goal of reducing its carbon emissions, which contribute 3-5% of global CO2 pollution. Solidia’s processes start with an energy-saving, sustainable cement, then cure concrete with CO2 , reduce the carbon footprint of cement and concrete up to 70%, and recycle 60 to 80% of the water used in production. Using the same raw materials and existing equipment as traditional concretes, the resulting products are higher performing, cost less to produce, and cure in less than 24 hours.
“Our next-generation concrete offers a competitive edge to the global US$1 trillion concrete and US$300 billion cement markets, advancing profitability and sustainability in an industry that needs both,” said Solidia President and CEO Tom Schuler .
Currently in commercialization for large- and small-scale applications, the initial technology focus was on unreinforced precast applications, including pavers and blocks. Solidia is now developing processes for reinforced applications, including aerated concrete, railroad ties, architectural panels and hollow core extrusions.
Solidia’s patent estate includes over 200 patent applications worldwide, with 32 issued and 14 scheduled. Investors include Kleiner Perkins Caufield & Byers , Bright Capital , BASF , BP , LafargeHolcim , Total Energy Ventures , Air Liquide , OGCI Climate Investments , Bill Joy and other private investors.
Ellen Yui, 301-270-8571
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
DE-INCYTE21.10.2018 12:47 | pressemeddelelse
Incyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Selective FGFR Inhibitor, in Patients with Cholangiocarcinoma
SERVIER21.10.2018 11:12 | pressemeddelelse
Servier and Taiho Oncology Announce Phase III LONSURF® Study Has Met Primary and Secondary Endpoints Demonstrating Prolonged Overall Survival and Progression-Free Survival in Patients with Refractory Metastatic Gastric Cancer
IL-GILEAD-SCIENCES21.10.2018 00:32 | pressemeddelelse
Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting
CA-TRUE-RELIGION19.10.2018 19:39 | pressemeddelelse
Manchester United and True Religion Launch Denim Range
ARCH-INSURANCE19.10.2018 15:12 | pressemeddelelse
Arch Insurance Announces Strategic Leadership Changes
MA-TAKEDA-PHARMACEUTICAL19.10.2018 14:02 | pressemeddelelse
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum